| 000 | 01378 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250516103003.0 | ||
| 264 | 0 | _c20130422 | |
| 008 | 201304s 0 0 eng d | ||
| 022 | _a1365-2265 | ||
| 024 | 7 |
_a10.1111/j.1365-2265.2012.04509.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchenk, Daniel | |
| 245 | 0 | 0 |
_aWhich antithyroid drug regimen in paediatric Graves' disease? _h[electronic resource] |
| 260 |
_bClinical endocrinology _cDec 2012 |
||
| 300 |
_a806-7 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAntithyroid Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCarbimazole _xtherapeutic use |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aDrug Dosage Calculations |
| 650 | 0 | 4 |
_aGraves Disease _xdrug therapy |
| 650 | 0 | 4 | _aHormone Replacement Therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 |
_aPropylthiouracil _xadverse effects |
| 650 | 0 | 4 |
_aThyroid Hormones _xadministration & dosage |
| 650 | 0 | 4 |
_aUnited Kingdom _xepidemiology |
| 700 | 1 | _aDonaldson, Malcolm | |
| 700 | 1 | _aCheetham, Tim | |
| 773 | 0 |
_tClinical endocrinology _gvol. 77 _gno. 6 _gp. 806-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2265.2012.04509.x _zAvailable from publisher's website |
| 999 |
_c21961789 _d21961789 |
||